Replies to post #70312 on Avid Bioservices Inc (CDMO)

[atonewith PPHM]

CP, I agree. Thank you for your common sense rebuttals! It is good to have someone who can rationalize, with facts, some of the speculative postings on the board.
At one with PPHM

[geocappy1]

I think the point everyone is missing is unless the various drugs being discussed cure 100% of the patients and rid them of 100% of the virus then Bavi may have a seat at the table. Because no other candidate works in the same way as Bavi it is unique in what it brings to the table.

[jonnyrocket]

Not sure you and everbody know this, but VRUS recently released data from their ELECTRON study of their drug PSI-7977 - it had 100% SVR in genotype 2/3 for HCV including in the interferon-free arm. They are moving on to Phase 3. I believe they and INHX are also running trials for genotype 1 that are interferon-free and all oral treatment, though would have to double check that - I thought I remember reading that recently though.

Recent articles I've read have said that the HCV market is moving towards Interferon-free and oral-only (pill form) treatments. I really hope that 1) the Bavi results are good for HCV as interferon replacement, 2) that some BP sees value in Bavi even though it cannot be taken orally, and 3) that a deal is already in the works (like I'm sure the ANDS deal was which was announced just a week after their data release) and is pending based on data...PPHM needs money. Why do I get the feeling that a good portion of that 2.5m volume on Friday was the ATM at work like Jake said. Too bad they can't just let it run There seems to be an unlimited number of shares for sale at this low-$1's price.

Hopefully we get something on Cotara FDA phase 3 planning mtg outcome real soon. Let's sell Cotara and Bavi for HCV, so we have enough cash to focus on the Bavi AC trials without having to do anymore financings at all time low prices. Get it done Tustin.